Disposition of 6698 shares by Heggie Theresa of BioCryst Pharmaceuticals at 6.11 subject to Rule 16b-3
| BCRX Stock | USD 7.70 0.13 1.66% |
Slightly above 61% of BioCryst Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading BioCryst Pharmaceuticals stock suggests that many investors are alarmed at this time. BioCryst Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, BioCryst Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
BioCryst |
Filed transaction by BioCryst Pharmaceuticals Director. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at news.google.com
 |
BioCryst Pharmaceuticals Fundamental Analysis
We analyze BioCryst Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioCryst Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioCryst Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
BioCryst Pharmaceuticals is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
BioCryst Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioCryst Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of BioCryst Pharmaceuticals could also be used in its relative valuation, which is a method of valuing BioCryst Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
BioCryst Pharmaceuticals Related Equities
| ATRA | Atara Biotherapeutics | 15.47 | ||||
| MCRB | Seres Therapeutics | 8.33 | ||||
| IMUX | Immunic | 7.84 | ||||
| INMB | INmune Bio | 7.51 | ||||
| CGTX | Cognition Therapeutics | 5.56 | ||||
| SAVA | Cassava Sciences | 5.09 | ||||
| KZR | Kezar Life | 4.41 | ||||
| VKTX | Viking Therapeutics | 4.30 | ||||
| PDSB | PDS Biotechnology | 4.05 | ||||
| BIVI | Biovie | 2.29 | ||||
| MDGL | Madrigal Pharmaceuticals | 1.88 | ||||
| AVXL | Anavex Life | 1.65 | ||||
| BPMC | Blueprint Medicines | 1.32 | ||||
| APLS | Apellis Pharmaceuticals | 0.90 | ||||
| DAWN | Day One | 0.94 | ||||
| AXSM | Axsome Therapeutics | 1.00 | ||||
| XFOR | X4 Pharmaceuticals | 1.33 | ||||
| TGTX | TG Therapeutics | 3.25 |
Additional Tools for BioCryst Stock Analysis
When running BioCryst Pharmaceuticals' price analysis, check to measure BioCryst Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCryst Pharmaceuticals is operating at the current time. Most of BioCryst Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of BioCryst Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCryst Pharmaceuticals' price. Additionally, you may evaluate how the addition of BioCryst Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.